Home / Compare / Orforglipron vs Tirzepatide
Orforglipron vs Tirzepatide
Orforglipron vs Tirzepatide: how they work, doses used, FDA status and trial weight loss (about 12% vs 20.9%), with sources.
| Orforglipron | Tirzepatide | |
|---|---|---|
| Works on | GLP-1 only (small molecule, not a peptide) | GIP + GLP-1 (dual agonist) |
| How it is taken | Tablet, once daily (Foundayo) | Injection, once weekly (Mounjaro, Zepbound) |
| US status | FDA-approved April 2026 (weight) | FDA-approved (2022 diabetes, 2023 weight) |
| Highest dose | 17.2 mg daily (label) | 15 mg weekly (label) |
| Key trial | ATTAIN-1 (phase 3) | SURMOUNT-1 (phase 3) |
| Average weight loss | about 12% at 72 weeks (highest dose) | 20.9% at 72 weeks (15 mg weekly) |
| Placebo in that trial | about 1-2% | 3.1% |
Not a head-to-head comparison. The weight-loss numbers come from separate trials with different people, doses and lengths. A direct trial is the only way to know which works better.
How they differ
Orforglipron works on glp-1 only (small molecule, not a peptide); Tirzepatide works on gip + glp-1 (dual agonist). Orforglipron is taken as: tablet, once daily (foundayo).Tirzepatide is taken as: injection, once weekly (mounjaro, zepbound).
Dose schedules and warnings: Orforglipron dosage chart ยท Tirzepatide dosage chart.
Questions
- Is orforglipron stronger than tirzepatide?
- No trial has compared them directly. In separate trials, Orforglipron averaged about 12% weight loss (ATTAIN-1 (phase 3), 72 weeks) and Tirzepatide 20.9% (SURMOUNT-1 (phase 3), 72 weeks). Different trials enroll different people over different lengths of time, so the numbers are not a fair head-to-head comparison.
- Is orforglipron FDA-approved?
- FDA-approved April 2026 (weight).
- Is tirzepatide FDA-approved?
- FDA-approved (2022 diabetes, 2023 weight).
Sources
- Healio: FDA approves orforglipron, an oral GLP-1, for adults with obesity (Apr 2026)
- Jastreboff et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). NEJM 2022
Last checked 2026-11-16. How we pick and check sources: methodology.